Original Article
Copyright ©2013 Baishideng Publishing Group Co., Limited. All rights reserved.
World J Immunol. Mar 27, 2013; 3(1): 7-14
Published online Mar 27, 2013. doi: 10.5411/wji.v3.i1.7
Eotaxin-2 blockade ameliorates experimental autoimmune encephalomyelitis
Karin Mausner-Fainberg, Arnon Karni, Jacob George, Michal Entin-Meer, Arnon Afek
Karin Mausner-Fainberg, Arnon Karni, Department of Neurology, The Neuroimmunology Laboratory, 64239 Tel Aviv, Israel
Jacob George, Department of Cardiology, Kaplan Medical Center, Rehovot, 64239 Tel Aviv, Israel
Michal Entin-Meer, Department of Cardiology, TASMC, 64239 Tel Aviv, Israel
Karin Mausner-Fainberg, Arnon Karni, Jacob George, Michal Entin-Meer, Arnon Afek, Sackler’s Medical School, Tel Aviv University, 64239 Tel Aviv, Israel
Arnon Afek, Sheba Medical Center, Tel Hashomer, 52621 Ramat Gan, Israel
Author contributions: All the authors contributed equally to this paper.
Correspondence to: Dr. Arnon Karni, Department of Neurology, The Neuroimmunology Laboratory, Tel Aviv Sourasky Medical Center, 6 Weizman Street, 64239 Tel Aviv, Israel. arnonk@tasmc.health.gov.il
Telephone: +97-2-3-6973424 Fax: +97-2-3-6974380
Received: November 3, 2011
Revised: March 12, 2012
Accepted: December 23, 2012
Published online: March 27, 2013
Core Tip